Hepatorenal index as an accurate, simple, and effective tool in screening for steatosis

American Journal of Roentgenology

Volumn 199, Issue 5, 2012, Pages 997-1002

  Marshall, Richard H ^a   Eissa, Marna ^a   Bluth, Edward I ^a   Gulotta, Paul M ^a   Davis, Nancy K ^a  

^a OCHSNER CLINIC FOUNDATION   (United States)

Author keywords

Hepatorenal index; Liver biopsy; Steatosis

Indexed keywords

ACCURACY; ADULT; ARTICLE; COMPUTER PROGRAM; ECHOGRAPHY; FATTY LIVER; FEMALE; HEPATORENAL INDEX; HUMAN; HUMAN TISSUE; LIVER BIOPSY; MAJOR CLINICAL STUDY; MALE; PERCUTANEOUS BIOPSY; PREDICTIVE VALUE; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; RELIABILITY; SCORING SYSTEM; SCREENING TEST; SENSITIVITY AND SPECIFICITY; ULTRASOUND GUIDED PERCUTANEOUS LIVER BIOPSY;

ADULT; AGED; AGED, 80 AND OVER; BIOPSY; DIAGNOSIS, DIFFERENTIAL; FATTY LIVER; FEMALE; HUMANS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX; SOFTWARE; ULTRASONOGRAPHY, INTERVENTIONAL;

EID: 84868020721     PISSN: 0361803X     EISSN: 15463141     Source Type: Journal    
DOI: 10.2214/AJR.11.6677     Document Type: Article

References (35)

1. Mishra P, Younossi ZM. Abdominal ultrasound for diagnosis of nonalcoholic fatty liver disease (NAFLD). Am J Gastroenterol 2007;102:2716-2717 (Pubitemid 350179334)
2. Qayyum A, Chen DM, Breiman RS, et al. Evaluation of diffuse liver steatosis by ultrasound, computed tomography, and magnetic resonance imaging: which modality is best? Clin Imaging 2009;33:110-115
3. Wanless IR, Lentz JS. Fatty liver hepatitis (steatohepatitis) and obesity: an autopsy study with analysis of risk factors. Hepatology 1990;12:1106-1110
4. Browning JD, Horton JD. Molecular mediators of hepatic steatosis and liver injury. J Clin Invest 2004;114:147-152 (Pubitemid 39071617)
5. Larter CZ, Chitturi S, Heydet D, Farrell GC. A fresh look at NASH pathogenesis. Part 1. The metabolic movers. J Gastroenterol Hepatol 2010;25:672-690
6. Feldstein AE, Charatcharoenwitthaya P, Treeprasertsuk S, Benson JT, Enders FB, Angulo P. The natural history of non-alcoholic fatty liver disease in children: a follow-up study for up to 20 years. Gut 2009;58:1538-1544
7. Adams LA, Harmsen S, St Sauver JL, et al. Nonalcoholic fatty liver disease increases risk of death among patients with diabetes: a community-based cohort study. Am J Gastroenterol 2010;105:1567-1573
8. Harrison SA, Brunt EM, Qazi RA, et al. Effect of significant histologic steatosis or steatohepatitis on response to antiviral therapy in patients with chronic hepatitis C. Clin Gastroenterol Hepatol 2005;3:604-609 (Pubitemid 40824754)
9. Webb M, Yeshua H, Zelber-Sagi S, et al. Diagnostic value of a computerized hepatorenal index for sonographic quantification of liver steatosis. AJR 2009;192:909-914
10. Bravo AA, Sheth SG, Chopra S. Liver biopsy. N Engl J Med 2001;344:495-500 (Pubitemid 32164902)
11. Soder RB, Baldisserotto M, Duval Da Silva V. Computer-assisted ultrasound analysis of liver echogenicity in obese and normal-weight children. AJR 2009;192:1316; [web]W201-W205
12. Yokoo T, Bydder M, Hamilton G, et al. Nonalcoholic fatty liver disease: diagnostic and fat-grading accuracy of low-flip-angle multiecho gradientrecalled-echo MR imaging at 1.5 T. Radiology 2009;251:67-76
13. Ducommun JC, Goldberg HI, Korobkin M, Moss AA, Kressel HY. The relation of liver fat to computed tomography numbers: a preliminary experimental study in rabbits. Radiology 1979;130:511-513 (Pubitemid 9098921)
14. Hamer OW, Aguirre DA, Casola G, Sirlin CB. Imaging features of perivascular fatty infiltration of the liver: initial observations. Radiology 2005;237:159-169 (Pubitemid 41346160)
15. Piekarski J, Goldberg HI, Royal SA, Axel L, Moss AA. Difference between liver and spleen CT numbers in the normal adult: its usefulness in predicting the presence of diffuse liver disease. Radiology 1980;137:727-729 (Pubitemid 11203707)
16. Iwasaki M, Takada Y, Hayashi M, et al. Noninvasive evaluation of graft steatosis in living donor liver transplantation. Transplantation 2004;78:1501-1505 (Pubitemid 39552937)
17. Park SH, Kim PN, Kim KW, et al. Macrovesicular hepatic steatosis in living liver donors: use of CT for quantitative and qualitative assessment. Radiology 2006;239:105-112
18. Palmentieri B, De Sio I, La Mura V, et al. The role of bright liver echo pattern on ultrasound B-mode examination in the diagnosis of liver steatosis. Dig Liver Dis 2006;38:485-489 (Pubitemid 44356237)
19. Schwenzer NF, Springer F, Schraml C, Stefan N, Machann J, Schick F. Non-invasive assessment and quantification of liver steatosis by ultrasound, computed tomography and magnetic resonance. J Hepatol 2009;51:433-445
20. Jeong JW, Lee S, Won Lee J, Yoo DS, Kim S. Computer-assisted sonographic analysis of the hepatorenal and textural features for the diagnosis of the fatty liver. Conf Proc IEEE Eng Med Biol Soc 2005;3:3348-3350 (Pubitemid 46229643)
21. Maeda K, Utsu M, Kihaile PE. Quantification of sonographic echogenicity with grey-level histogram width: a clinical tissue characterization. Ultrasound Med Biol 1998;24:225-234 (Pubitemid 28145711)
22. Strauss S, Gavish E, Gottlieb P, Katsnelson L. Interobserver and intraobserver variability in the sonographic assessment of fatty liver. AJR 2007;189:1449; [web]W320-W323 (Pubitemid 350174809)
23. Poynard T, Morra R, Halfon P, et al. Meta-analyses of FibroTest diagnostic value in chronic liver disease. BMC Gastroenterol 2007;7:40
24. Walsh MJ, Vanags DM, Clouston AD, et al. Steatosis and liver cell apoptosis in chronic hepatitis C: a mechanism for increased liver injury. Hepatology 2004;39:1230-1238 (Pubitemid 38569044)
25. Anastasiou J, Alisa A, Virtue S, et al. Noninvasive markers of fibrosis and inflammation in clinical practice: prospective comparison with liver biopsy. Eur J Gastroenterol Hepatol 2010;22:474-480
26. Tarantino G, Conca P, Pasanisi F, et al. Could inflammatory markers help diagnose nonalcoholic steatohepatitis? Eur J Gastroenterol Hepatol 2009;21:504-511
27. Poynard T, Imbert-Bismut F, Munteanu M, et al. Overview of the diagnostic value of biochemical markers of liver fibrosis (FibroTest, HCV Fibro-Sure) and necrosis (ActiTest) in patients with chronic hepatitis C. Comp Hepatol 2004;3:8
28. Wieckowska A, Papouchado BG, Li Z, Lopez R, Zein NN, Feldstein AE. Increased hepatic and circulating interleukin-6 levels in human nonalcoholic steatohepatitis. Am J Gastroenterol 2008;103:1372-1379 (Pubitemid 351813900)
29. Lim AK, Taylor-Robinson SD, Patel N, et al. Hepatic vein transit times using a microbubble agent can predict disease severity non-invasively in patients with hepatitis C. Gut 2005;54:128-133 (Pubitemid 40007232)
30. Ogden CL, Carroll MD, Curtin LR, et al. Prevalence of overweight and obesity in the United States, 1999-2004. JAMA 2006;295:1549-1555
31. Angulo P. Nonalcoholic fatty liver disease. N Engl J Med 2002;346:1221-1231
32. Rakoski MO, Singal AG, Rogers M A M, Conjeevaram H. Meta-analysis: insulin sensitizers for the treatment of non-alcoholic steatohepatitis. Aliment Pharmacol Ther 2010;32:1211-1221
33. Armstrong GL, Wasley A, Simard EP, et al. The prevalence of hepatitis C virus infection in the United States, 1999 through 2002. Ann Intern Med 2006;144:705-714 (Pubitemid 46780630)
34. Wasley A, Kruszon-Moran D, Kuhnert W, et al. The prevalence of hepatitis B virus infection in the United States in the era of vaccination. J Infect Dis 2010;202:192-201
35. Coresh J, Selvin E, Stevens LA, et al. Prevalence of chronic kidney disease in the United States. JAMA 2007;298:2038-2047 (Pubitemid 350074801)